U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457255) titled 'Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment' on Feb. 18.
Brief Summary: This interventional study evaluates the late endocrine and metabolic consequences of treatment of primary brain tumors in childhood. Childhood brain tumor survivors are at increased risk of developing long-term complications such as hormonal deficiencies, obesity, impaired growth, dyslipidemia, and other metabolic disorders, which may significantly affect long-term health and quality of life.
The aim of this study is to assess the prevalence and severity of endocrine and metabolic late effects in patients treated for brain t...